A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session04970143c4cb7237ec5767124b6e28c35df767e5): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Drug of Abuse Screening Market Insights, Forecast to 2034

img

Global Drug of Abuse Screening Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug of Abuse Screening Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Drug of Abuse Screening Market
Global Drug of Abuse Screening market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Drug of Abuse Screening industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Drug of Abuse Screening market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Drug of Abuse Screening market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories, Inc.
Thermo Fisher Scientific
LabCorp (Laboratory Corporation of America)
Psychemedics Corporation
Sonic Healthcare
Bio-Rad Laboratories
Quest Diagnostics
Randox Laboratories
F. Hoffman-La Roche
Segment by Type
On-Site Screening
Laboratory-Based Screening

Segment by Application


Medical
Research
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Drug of Abuse Screening introduction, etc. Drug of Abuse Screening Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Drug of Abuse Screening
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug of Abuse Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 On-Site Screening
1.2.3 Laboratory-Based Screening
1.3 Market by Application
1.3.1 Global Drug of Abuse Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Medical
1.3.3 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug of Abuse Screening Market Perspective (2018-2033)
2.2 Global Drug of Abuse Screening Growth Trends by Region
2.2.1 Drug of Abuse Screening Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Drug of Abuse Screening Historic Market Size by Region (2018-2023)
2.2.3 Drug of Abuse Screening Forecasted Market Size by Region (2024-2033)
2.3 Drug of Abuse Screening Market Dynamics
2.3.1 Drug of Abuse Screening Industry Trends
2.3.2 Drug of Abuse Screening Market Drivers
2.3.3 Drug of Abuse Screening Market Challenges
2.3.4 Drug of Abuse Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Drug of Abuse Screening by Players
3.1.1 Global Drug of Abuse Screening Revenue by Players (2018-2023)
3.1.2 Global Drug of Abuse Screening Revenue Market Share by Players (2018-2023)
3.2 Global Drug of Abuse Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Drug of Abuse Screening, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Drug of Abuse Screening Market Concentration Ratio
3.4.1 Global Drug of Abuse Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug of Abuse Screening Revenue in 2022
3.5 Global Key Players of Drug of Abuse Screening Head office and Area Served
3.6 Global Key Players of Drug of Abuse Screening, Product and Application
3.7 Global Key Players of Drug of Abuse Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug of Abuse Screening Breakdown Data by Type
4.1 Global Drug of Abuse Screening Historic Market Size by Type (2018-2023)
4.2 Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033)
5 Drug of Abuse Screening Breakdown Data by Application
5.1 Global Drug of Abuse Screening Historic Market Size by Application (2018-2023)
5.2 Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Drug of Abuse Screening Market Size (2018-2033)
6.2 North America Drug of Abuse Screening Market Size by Type
6.2.1 North America Drug of Abuse Screening Market Size by Type (2018-2023)
6.2.2 North America Drug of Abuse Screening Market Size by Type (2024-2033)
6.2.3 North America Drug of Abuse Screening Market Share by Type (2018-2033)
6.3 North America Drug of Abuse Screening Market Size by Application
6.3.1 North America Drug of Abuse Screening Market Size by Application (2018-2023)
6.3.2 North America Drug of Abuse Screening Market Size by Application (2024-2033)
6.3.3 North America Drug of Abuse Screening Market Share by Application (2018-2033)
6.4 North America Drug of Abuse Screening Market Size by Country
6.4.1 North America Drug of Abuse Screening Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Drug of Abuse Screening Market Size by Country (2018-2023)
6.4.3 North America Drug of Abuse Screening Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Drug of Abuse Screening Market Size (2018-2033)
7.2 Europe Drug of Abuse Screening Market Size by Type
7.2.1 Europe Drug of Abuse Screening Market Size by Type (2018-2023)
7.2.2 Europe Drug of Abuse Screening Market Size by Type (2024-2033)
7.2.3 Europe Drug of Abuse Screening Market Share by Type (2018-2033)
7.3 Europe Drug of Abuse Screening Market Size by Application
7.3.1 Europe Drug of Abuse Screening Market Size by Application (2018-2023)
7.3.2 Europe Drug of Abuse Screening Market Size by Application (2024-2033)
7.3.3 Europe Drug of Abuse Screening Market Share by Application (2018-2033)
7.4 Europe Drug of Abuse Screening Market Size by Country
7.4.1 Europe Drug of Abuse Screening Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Drug of Abuse Screening Market Size by Country (2018-2023)
7.4.3 Europe Drug of Abuse Screening Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Drug of Abuse Screening Market Size (2018-2033)
8.2 China Drug of Abuse Screening Market Size by Type
8.2.1 China Drug of Abuse Screening Market Size by Type (2018-2023)
8.2.2 China Drug of Abuse Screening Market Size by Type (2024-2033)
8.2.3 China Drug of Abuse Screening Market Share by Type (2018-2033)
8.3 China Drug of Abuse Screening Market Size by Application
8.3.1 China Drug of Abuse Screening Market Size by Application (2018-2023)
8.3.2 China Drug of Abuse Screening Market Size by Application (2024-2033)
8.3.3 China Drug of Abuse Screening Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Drug of Abuse Screening Market Size (2018-2033)
9.2 Asia Drug of Abuse Screening Market Size by Type
9.2.1 Asia Drug of Abuse Screening Market Size by Type (2018-2023)
9.2.2 Asia Drug of Abuse Screening Market Size by Type (2024-2033)
9.2.3 Asia Drug of Abuse Screening Market Share by Type (2018-2033)
9.3 Asia Drug of Abuse Screening Market Size by Application
9.3.1 Asia Drug of Abuse Screening Market Size by Application (2018-2023)
9.3.2 Asia Drug of Abuse Screening Market Size by Application (2024-2033)
9.3.3 Asia Drug of Abuse Screening Market Share by Application (2018-2033)
9.4 Asia Drug of Abuse Screening Market Size by Region
9.4.1 Asia Drug of Abuse Screening Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Drug of Abuse Screening Market Size by Region (2018-2023)
9.4.3 Asia Drug of Abuse Screening Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Type
10.2.1 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Drug of Abuse Screening Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Application
10.3.1 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Drug of Abuse Screening Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country
10.4.1 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories, Inc.
11.1.1 Abbott Laboratories, Inc. Company Details
11.1.2 Abbott Laboratories, Inc. Business Overview
11.1.3 Abbott Laboratories, Inc. Drug of Abuse Screening Introduction
11.1.4 Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2018-2023)
11.1.5 Abbott Laboratories, Inc. Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Drug of Abuse Screening Introduction
11.2.4 Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 LabCorp (Laboratory Corporation of America)
11.3.1 LabCorp (Laboratory Corporation of America) Company Details
11.3.2 LabCorp (Laboratory Corporation of America) Business Overview
11.3.3 LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Introduction
11.3.4 LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2018-2023)
11.3.5 LabCorp (Laboratory Corporation of America) Recent Developments
11.4 Psychemedics Corporation
11.4.1 Psychemedics Corporation Company Details
11.4.2 Psychemedics Corporation Business Overview
11.4.3 Psychemedics Corporation Drug of Abuse Screening Introduction
11.4.4 Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2018-2023)
11.4.5 Psychemedics Corporation Recent Developments
11.5 Sonic Healthcare
11.5.1 Sonic Healthcare Company Details
11.5.2 Sonic Healthcare Business Overview
11.5.3 Sonic Healthcare Drug of Abuse Screening Introduction
11.5.4 Sonic Healthcare Revenue in Drug of Abuse Screening Business (2018-2023)
11.5.5 Sonic Healthcare Recent Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Details
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Drug of Abuse Screening Introduction
11.6.4 Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Developments
11.7 Quest Diagnostics
11.7.1 Quest Diagnostics Company Details
11.7.2 Quest Diagnostics Business Overview
11.7.3 Quest Diagnostics Drug of Abuse Screening Introduction
11.7.4 Quest Diagnostics Revenue in Drug of Abuse Screening Business (2018-2023)
11.7.5 Quest Diagnostics Recent Developments
11.8 Randox Laboratories
11.8.1 Randox Laboratories Company Details
11.8.2 Randox Laboratories Business Overview
11.8.3 Randox Laboratories Drug of Abuse Screening Introduction
11.8.4 Randox Laboratories Revenue in Drug of Abuse Screening Business (2018-2023)
11.8.5 Randox Laboratories Recent Developments
11.9 F. Hoffman-La Roche
11.9.1 F. Hoffman-La Roche Company Details
11.9.2 F. Hoffman-La Roche Business Overview
11.9.3 F. Hoffman-La Roche Drug of Abuse Screening Introduction
11.9.4 F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2018-2023)
11.9.5 F. Hoffman-La Roche Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug of Abuse Screening Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of On-Site Screening
Table 3. Key Players of Laboratory-Based Screening
Table 4. Global Drug of Abuse Screening Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Drug of Abuse Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Drug of Abuse Screening Market Share by Region (2018-2023)
Table 8. Global Drug of Abuse Screening Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Drug of Abuse Screening Market Share by Region (2024-2033)
Table 10. Drug of Abuse Screening Market Trends
Table 11. Drug of Abuse Screening Market Drivers
Table 12. Drug of Abuse Screening Market Challenges
Table 13. Drug of Abuse Screening Market Restraints
Table 14. Global Drug of Abuse Screening Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Drug of Abuse Screening Revenue Share by Players (2018-2023)
Table 16. Global Top Drug of Abuse Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
Table 17. Global Drug of Abuse Screening Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Drug of Abuse Screening Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Drug of Abuse Screening, Headquarters and Area Served
Table 20. Global Key Players of Drug of Abuse Screening, Product and Application
Table 21. Global Key Players of Drug of Abuse Screening, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Drug of Abuse Screening Revenue Market Share by Type (2018-2023)
Table 25. Global Drug of Abuse Screening Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Drug of Abuse Screening Revenue Market Share by Type (2024-2033)
Table 27. Global Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Drug of Abuse Screening Revenue Share by Application (2018-2023)
Table 29. Global Drug of Abuse Screening Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Drug of Abuse Screening Revenue Share by Application (2024-2033)
Table 31. North America Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Drug of Abuse Screening Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Drug of Abuse Screening Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Drug of Abuse Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Drug of Abuse Screening Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Drug of Abuse Screening Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Drug of Abuse Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Drug of Abuse Screening Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Drug of Abuse Screening Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Drug of Abuse Screening Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Drug of Abuse Screening Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Drug of Abuse Screening Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Drug of Abuse Screening Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Drug of Abuse Screening Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Drug of Abuse Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size by Country (2024-2033) & (US$ Million)
Table 63. Abbott Laboratories, Inc. Company Details
Table 64. Abbott Laboratories, Inc. Business Overview
Table 65. Abbott Laboratories, Inc. Drug of Abuse Screening Product
Table 66. Abbott Laboratories, Inc. Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 67. Abbott Laboratories, Inc. Recent Developments
Table 68. Thermo Fisher Scientific Company Details
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Drug of Abuse Screening Product
Table 71. Thermo Fisher Scientific Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Developments
Table 73. LabCorp (Laboratory Corporation of America) Company Details
Table 74. LabCorp (Laboratory Corporation of America) Business Overview
Table 75. LabCorp (Laboratory Corporation of America) Drug of Abuse Screening Product
Table 76. LabCorp (Laboratory Corporation of America) Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 77. LabCorp (Laboratory Corporation of America) Recent Developments
Table 78. Psychemedics Corporation Company Details
Table 79. Psychemedics Corporation Business Overview
Table 80. Psychemedics Corporation Drug of Abuse Screening Product
Table 81. Psychemedics Corporation Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 82. Psychemedics Corporation Recent Developments
Table 83. Sonic Healthcare Company Details
Table 84. Sonic Healthcare Business Overview
Table 85. Sonic Healthcare Drug of Abuse Screening Product
Table 86. Sonic Healthcare Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 87. Sonic Healthcare Recent Developments
Table 88. Bio-Rad Laboratories Company Details
Table 89. Bio-Rad Laboratories Business Overview
Table 90. Bio-Rad Laboratories Drug of Abuse Screening Product
Table 91. Bio-Rad Laboratories Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 92. Bio-Rad Laboratories Recent Developments
Table 93. Quest Diagnostics Company Details
Table 94. Quest Diagnostics Business Overview
Table 95. Quest Diagnostics Drug of Abuse Screening Product
Table 96. Quest Diagnostics Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 97. Quest Diagnostics Recent Developments
Table 98. Randox Laboratories Company Details
Table 99. Randox Laboratories Business Overview
Table 100. Randox Laboratories Drug of Abuse Screening Product
Table 101. Randox Laboratories Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 102. Randox Laboratories Recent Developments
Table 103. F. Hoffman-La Roche Company Details
Table 104. F. Hoffman-La Roche Business Overview
Table 105. F. Hoffman-La Roche Drug of Abuse Screening Product
Table 106. F. Hoffman-La Roche Revenue in Drug of Abuse Screening Business (2018-2023) & (US$ Million)
Table 107. F. Hoffman-La Roche Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Drug of Abuse Screening Market Share by Type: 2022 VS 2033
Figure 3. On-Site Screening Features
Figure 4. Laboratory-Based Screening Features
Figure 5. Global Drug of Abuse Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Drug of Abuse Screening Market Share by Application: 2022 VS 2033
Figure 7. Medical Case Studies
Figure 8. Research Case Studies
Figure 9. Drug of Abuse Screening Report Years Considered
Figure 10. Global Drug of Abuse Screening Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Drug of Abuse Screening Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Drug of Abuse Screening Market Share by Region: 2022 VS 2033
Figure 13. Global Drug of Abuse Screening Market Share by Players in 2022
Figure 14. Global Top Drug of Abuse Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse Screening as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drug of Abuse Screening Revenue in 2022
Figure 16. North America Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Drug of Abuse Screening Market Share by Type (2018-2033)
Figure 18. North America Drug of Abuse Screening Market Share by Application (2018-2033)
Figure 19. North America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 20. United States Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Drug of Abuse Screening Market Size YoY (2018-2033) & (US$ Million)
Figure 23. Europe Drug of Abuse Screening Market Share by Type (2018-2033)
Figure 24. Europe Drug of Abuse Screening Market Share by Application (2018-2033)
Figure 25. Europe Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 26. Germany Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. China Drug of Abuse Screening Market Size YoY (2018-2033) & (US$ Million)
Figure 33. China Drug of Abuse Screening Market Share by Type (2018-2033)
Figure 34. China Drug of Abuse Screening Market Share by Application (2018-2033)
Figure 35. Asia Drug of Abuse Screening Market Size YoY (2018-2033) & (US$ Million)
Figure 36. Asia Drug of Abuse Screening Market Share by Type (2018-2033)
Figure 37. Asia Drug of Abuse Screening Market Share by Application (2018-2033)
Figure 38. Asia Drug of Abuse Screening Market Share by Region (2018-2033)
Figure 39. Japan Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. South Korea Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. China Taiwan Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Southeast Asia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. India Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Australia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Drug of Abuse Screening Market Size YoY (2018-2033) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Drug of Abuse Screening Market Share by Type (2018-2033)
Figure 47. Middle East, Africa, and Latin America Drug of Abuse Screening Market Share by Application (2018-2033)
Figure 48. Middle East, Africa, and Latin America Drug of Abuse Screening Market Share by Country (2018-2033)
Figure 49. Brazil Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Mexico Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Turkey Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Saudi Arabia Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Israel Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. GCC Countries Drug of Abuse Screening Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Abbott Laboratories, Inc. Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 57. LabCorp (Laboratory Corporation of America) Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 58. Psychemedics Corporation Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 59. Sonic Healthcare Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 61. Quest Diagnostics Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 62. Randox Laboratories Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 63. F. Hoffman-La Roche Revenue Growth Rate in Drug of Abuse Screening Business (2018-2023)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed